Point72 Asset Management »

Oruka Therapeutics shares owned by Point72 Asset Management

Quarter-by-quarter ownership of Oruka Therapeutics shares owned by Point72 Asset Management from 13F filings

Historical chart of Point72 Asset Management investment in Oruka Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Oruka Therapeutics held by Point72 Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oruka Therapeutics by Point72 Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $12M 482k 24.51

More positions owned by Point72 Asset Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation (NVDA)
Shell Spon Ads (SHEL)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Arista Networks (ANET)
Comcast Corp Cl A (CMCSA)
Boston Scientific Corporation (BSX)
M/a (MTSI)
Lumentum Hldgs (LITE)
Intuitive Surgical Com New (ISRG)
Alphabet Cap Stk Cl A (GOOGL)
ConocoPhillips (COP)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Coherent Corp (COHR)

View all positions for Point72 Asset Management

Top funds holding Oruka Therapeutics

Fairmount Funds Management
VR Adviser
Commodore Capital
Perceptive Advisors
Avidity Partners Management
Franklin Resources
Paradigm Biocapital Advisors
Braidwell
Dr. Jeffrey R. Jay, M.D.
Point72 Asset Management
Frazier Life Sciences Management
Redmile Group
Woodline Partners
Affinity Asset Advisors
Driehaus Capital Management

View all funds holding Oruka Therapeutics